Narjust Florez, MD

Narjust Florez, MD

Medical Oncology

Languages Spoken:


Contact Information




Narjust Florez, MD

Dr. Narjust Florez is the Associate Director of the Cancer Care Equity Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center. She completed her internal medicine residency in Rutgers New Jersey Medical School and fellowship at the Mayo Clinic in Rochester, Minnesota where she was the chief fellow from 2018-2019.

Dr. Florez's clinical interests include targeted therapy for lung cancer and the care of women with lung cancer, including their unique aspects of cancer survivorship. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer.

Apart from her clinical interests in lung cancer, she is also a leading and productive researcher in cancer health disparities, gender and racial discrimination in medical education and medicine. She received many awards including the 2018 Resident of the Year Award by the National Hispanic Medical Association, the Mayo Brothers Distinguished Fellowship award and the 2020 Rising Star award by the LEAD national conference for women in hematology and oncology.

In addition, Dr. Florez founded the Florez Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine and medical education. The laboratory long-term goals are to create a welcoming environment for medical trainees from historically underrepresented groups in medicine while improving the care of vulnerable populations. Members of the Florez Lab are agents of change.



Associate Director, Cancer Care Equity Program
Member of the Faculty, Harvard Medical School


Clinical Interests

Cancer health disparities, Lung cancer in women, Lung cancer survivorship, Quality of life and symptom's control, Thoracic malignancies

Board Certification

  • Internal Medicine, 2016
  • Medical Oncology, 2019


  • Fred Hutchinson Cancer Research Center, Research
  • Mayo Clinic, Hematology/Medical Oncology


  • Rutgers University - New Jersey Medical School

Medical School

  • Universidad Catolica Nordestana


    • From Approximation to Precision: Fertility and Pregnancy Questions in Young Patients With Lung Cancer. J Thorac Oncol. 2024 Jun; 19(6):852-854. View in: Pubmed

    • Healthcare disparities, screening, and molecular testing in the changing landscape of non-small cell lung cancer in the United States: a review. Cancer Metastasis Rev. 2024 May 16. View in: Pubmed

    • Quality and Accessibility of Liquid Biopsy Information. JAMA Netw Open. 2024 May 01; 7(5):e2410171. View in: Pubmed

    • More than Cramps in Scrubs: Exploring Dysmenorrhea among Women Healthcare Workers. Int J Womens Health. 2024; 16:749-753. View in: Pubmed

    • Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis. Clin Lung Cancer. 2024 Apr 10. View in: Pubmed

    • Therapy for Stage IV Non-Small Cell Lung Cancer With and Without Driver Alterations: ASCO Living Guideline Clinical Insights. JCO Oncol Pract. 2024 Apr 08; OP2400177. View in: Pubmed

    • Precision Immuno-Oncology in NSCLC through Gender Equity Lenses. Cancers (Basel). 2024 Apr 04; 16(7). View in: Pubmed

    • Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRASG12C-Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review. JCO Precis Oncol. 2024 Apr; 8:e2300644. View in: Pubmed

    • Advancing Equity at the JAMA Network-Self-Reported Demographics of Editors and Editorial Board Members. JAMA. 2024 03 12; 331(10):837-839. View in: Pubmed

    • Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. J Clin Oncol. 2024 Apr 10; 42(11):e1-e22. View in: Pubmed

    • Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. J Clin Oncol. 2024 Apr 10; 42(11):e23-e43. View in: Pubmed

    • Challenges and Solutions to Support Oncology Professionals Serving Underserved Populations With Cancer in the United States: Results From the ASCO Serving the Underserved Task Force. JCO Oncol Pract. 2024 May; 20(5):688-698. View in: Pubmed

    • When the unimaginable happens: Lung cancer diagnosis during pregnancy. Cancer. 2024 Jun 01; 130(11):1905-1909. View in: Pubmed

    • Disparities in Stage at Presentation Among Hispanic and Latinx Patients With Non-Small-Cell Lung Cancer in the United States. JCO Oncol Pract. 2024 Apr; 20(4):525-537. View in: Pubmed

    • Latinas in medicine: evaluating and understanding the experience of Latinas in medical education: a cross sectional survey. BMC Med Educ. 2024 Jan 03; 24(1):4. View in: Pubmed

    • Can I Leave? Perspectives on Parental Leave and Parenthood in Medical Training Among Program Directors and Trainees in Oncologic Specialties. J Womens Health (Larchmt). 2024 Feb; 33(2):218-227. View in: Pubmed

    • Unconscious bias in speaker introductions at a national vascular surgery meeting: The impact of rank, race and gender. Am J Surg. 2024 Jun; 232:54-58. View in: Pubmed

    • Sexual dysfunction in patients with cancer, a challenge in oncology practice: results of the CLARIFY project. Clin Transl Oncol. 2024 May; 26(5):1147-1156. View in: Pubmed

    • Medical Travel for Immigrant Patients With Cancer-Returning Home. JAMA Oncol. 2023 Nov 01; 9(11):1493-1494. View in: Pubmed

    • Lung Cancer in Women: The Past, Present, and Future. Clin Lung Cancer. 2024 01; 25(1):1-8. View in: Pubmed

    • Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research Retreat. J Cancer Educ. 2024 Feb; 39(1):58-64. View in: Pubmed

    • Sexual Health Assessment in Women with Lung Cancer study: Sexual health assessment in women with lung cancer. Cancer. 2024 02 01; 130(3):375-384. View in: Pubmed

    • Women, power, and cancer: a Lancet Commission. Lancet. 2023 12 02; 402(10417):2113-2166. View in: Pubmed

    • Parent Penalty: Parental Leave Experiences of Trainees and Early-Career Faculty in Oncology Subspecialties. JCO Oncol Pract. 2023 Oct; 19(10):899-906. View in: Pubmed

    • Going Back Home: Understanding Physician Migration to the United States. JCO Glob Oncol. 2023 Sep; 9:e2300332. View in: Pubmed

    • The Impact of Climate Change on Global Oncology. Hematol Oncol Clin North Am. 2024 Feb; 38(1):105-121. View in: Pubmed

    • Enhancing Patient Retention in Clinical Trials-Strategies for Success. JAMA Oncol. 2023 08 01; 9(8):1031-1033. View in: Pubmed

    • Race/Ethnicity and Gender Representation in Hematology and Oncology Editorial Boards: What is the State of Diversity? Oncologist. 2023 07 05; 28(7):609-617. View in: Pubmed

    • Evolution of the Oncologist Clinician Educator. JCO Oncol Pract. 2023 09; 19(9):700-703. View in: Pubmed

    • Palliative Care for All? An Assessment of Racial and Ethnic Disparities Research With Solutions. J Pain Symptom Manage. 2023 10; 66(4):e521-e523. View in: Pubmed

    • Assessing the Needs of Those Who Serve the Underserved: A Qualitative Study among US Oncology Clinicians. Cancers (Basel). 2023 Jun 23; 15(13). View in: Pubmed

    • State of Cancer Control in South America: Challenges and Advancement Strategies. Hematol Oncol Clin North Am. 2024 Feb; 38(1):55-76. View in: Pubmed

    • An Overview of Cervical Cancer Prevention and Control in Latin America and the Caribbean Countries. Hematol Oncol Clin North Am. 2024 Feb; 38(1):13-33. View in: Pubmed

    • Inequity in care delivery in cardio-oncology: dissecting disparities in underrepresented populations. Front Oncol. 2023; 13:1124447. View in: Pubmed

    • Disparities in Diagnosis, Treatment Access, and Time to Treatment Among Hispanic Men With Metastatic Prostate Cancer. JCO Oncol Pract. 2023 08; 19(8):645-653. View in: Pubmed

    • Mentorship Experiences Are Not All the Same: A Survey Study of Oncology Trainees and Early-Career Faculty. JCO Oncol Pract. 2023 09; 19(9):808-818. View in: Pubmed

    • Disparities in lung cancer. J Natl Med Assoc. 2023 May; 115(2S):S46-S53. View in: Pubmed

    • Research Priorities for Interventions to Address Health Disparities in Lung Nodule Management: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2023 03 15; 207(6):e31-e46. View in: Pubmed

    • Demographic Representation Among Speakers and Program Committee Members at the IDWeek Conference, 2013-2021. Clin Infect Dis. 2023 03 04; 76(5):897-904. View in: Pubmed

    • Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.3. J Clin Oncol. 2023 04 10; 41(11):e31-e41. View in: Pubmed

    • Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.3. J Clin Oncol. 2023 04 10; 41(11):e21-e30. View in: Pubmed

    • Impact of a Biopsychosocial Screening Program on Clinical and Hospital-Based Outcomes in Cancer. JCO Oncol Pract. 2023 06; 19(6):e822-e828. View in: Pubmed

    • Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis. JAMA Oncol. 2023 02 01; 9(2):180-187. View in: Pubmed

    • Prevalence of Financial Toxicity Among Hispanic Cancer Survivors: A Nationally Representative Pan-Cancer Analysis. J Gen Intern Med. 2023 04; 38(5):1334-1337. View in: Pubmed

    • Racial and Ethnic Disparities in Opioid Access and Urine Drug Screening Among Older Patients With Poor-Prognosis Cancer Near the End of Life. J Clin Oncol. 2023 05 10; 41(14):2511-2522. View in: Pubmed

    • Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2. J Clin Oncol. 2023 02 10; 41(5):e10-e20. View in: Pubmed

    • Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2. J Clin Oncol. 2023 02 10; 41(5):e1-e9. View in: Pubmed

    • End-of-Life Care and Advanced Directives in Hispanic/Latinx Patients: Challenges and Solutions for the Practicing Oncologist. Oncologist. 2022 12 09; 27(12):1074-1080. View in: Pubmed

    • Disparities in cancer care-A call to action. Cancer Cell. 2023 01 09; 41(1):1-4. View in: Pubmed

    • ASO Visual Abstract: Disparities in Primary-Stage Breast Cancer at Presentation Among Hispanic Subgroups. Ann Surg Oncol. 2022 Dec; 29(13):7990-7991. View in: Pubmed

    • Evaluating Internal Medicine Residents' Awareness on Cancer Survivorship Care Plan: A Pilot Survey. J Community Hosp Intern Med Perspect. 2022; 12(6):12-18. View in: Pubmed

    • Understanding Modern Medical Centers: Beyond Simone-Intersectional Maxims for a New Era. J Clin Oncol. 2023 Mar 01; 41(7):1350-1358. View in: Pubmed

    • Starting a Career in Oncology: Fighting Cancer and Gender Disparities. JAMA Oncol. 2022 09 01; 8(9):1251-1252. View in: Pubmed

    • Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis. Front Oncol. 2022; 12:955440. View in: Pubmed

    • Disparities in Primary Breast Cancer Stage at Presentation Among Hispanic Subgroups. Ann Surg Oncol. 2022 Dec; 29(13):7977-7987. View in: Pubmed

    • Electronic Monitoring of Patient-Reported Outcomes-Ready for Prime Time? JAMA Oncol. 2022 08 01; 8(8):1099-1100. View in: Pubmed

    • Do no harm: A call to action on COVID-19 and mask requirements. Cancer. 2022 10 01; 128(19):3438-3440. View in: Pubmed

    • ASO Author Reflections: The Need for Disaggregated Study among Hispanic Populations. Ann Surg Oncol. 2022 12; 29(13):7988-7989. View in: Pubmed

    • Social Media and the Quest for Equity and Diversity in Oncology: On Safe Spaces and the Concept of the Public Physician. JCO Oncol Pract. 2022 08; 18(8):572-577. View in: Pubmed

    • Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline. J Clin Oncol. 2022 10 01; 40(28):3323-3343. View in: Pubmed

    • Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline. J Clin Oncol. 2022 10 01; 40(28):3310-3322. View in: Pubmed

    • My White Coat Doesn't Fit. J Clin Oncol. 2022 10 01; 40(28):3344-3345. View in: Pubmed

    • Disparities in Cancer Care and Scientific Knowledge in Hispanic/Latinx People in the United States. JCO Oncol Pract. 2022 05; 18(5):367-369. View in: Pubmed

    • Proyecto ELEVAR: Evaluating the Latinx Experience With the Health Care System Through Variables on Access and Resources. JCO Oncol Pract. 2022 05; 18(5):e814-e826. View in: Pubmed

    • Dónde Están? Latinx/Hispanic Representation in the Oncology Workforce: Present and Future. JCO Oncol Pract. 2022 05; 18(5):388-395. View in: Pubmed

    • The Problem of Hispanic/Latinx Under-Representation in Cancer Clinical Trials. JCO Oncol Pract. 2022 05; 18(5):380-384. View in: Pubmed

    • Disparities in Cardio-Oncology Care in the Hispanic/Latinx Population. JCO Oncol Pract. 2022 05; 18(5):404-409. View in: Pubmed

    • Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer. Clin Lung Cancer. 2022 07; 23(5):e317-e320. View in: Pubmed

    • Disparities in Representation of Women, Older Adults, and Racial/Ethnic Minorities in Immune Checkpoint Inhibitor Trials. Am J Med. 2022 08; 135(8):984-992.e6. View in: Pubmed

    • Adjust, don't avoid: The need for risk-based CT screening in nonsmoking populations. Lung Cancer. 2022 06; 168:36-37. View in: Pubmed

    • Microaggressions, Bias, and Equity in the Workplace: Why Does It Matter, and What Can Oncologists Do? Am Soc Clin Oncol Educ Book. 2022 Apr; 42:1-12. View in: Pubmed

    • Left Out: Disparities in Access to Care Among Foreign-Born Populations and Implications for Hospital-Based Studies. Am J Gastroenterol. 2022 06 01; 117(6):1011-1012. View in: Pubmed

    • Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men. Prostate Cancer Prostatic Dis. 2023 06; 26(2):309-316. View in: Pubmed

    • With one eye on the future. Cancer Cell. 2022 03 14; 40(3):221-225. View in: Pubmed

    • Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer. JAMA Netw Open. 2022 03 01; 5(3):e224304. View in: Pubmed

    • HOLA COVID-19 Study: Evaluating the Impact of Caring for Patients With COVID-19 on Cancer Care Delivery in Latin America. JCO Glob Oncol. 2022 03; 8:e2100251. View in: Pubmed

    • Immune checkpoint inhibitors and timing of administration. Lancet Oncol. 2022 02; 23(2):e56. View in: Pubmed

    • Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States. JAMA Netw Open. 2022 01 04; 5(1):e2142046. View in: Pubmed

    • Knowledge, Practice, and Attitudes of Physicians in Low- and Middle-Income Countries on Fertility and Pregnancy-Related Issues in Young Women With Breast Cancer. JCO Glob Oncol. 2022 01; 8:e2100153. View in: Pubmed

    • Women Oncologists' Perceptions and Factors Associated With Decisions to Pursue Academic vs Nonacademic Careers in Oncology. JAMA Netw Open. 2021 12 01; 4(12):e2141344. View in: Pubmed

    • COVID-19 and Cancer: A Review of the Registry-Based Pandemic Response. JAMA Oncol. 2021 12 01; 7(12):1882-1890. View in: Pubmed

    • Baby Steps in the Right Direction: Toward a Parental Leave Policy for Gastroenterology Fellows. Am J Gastroenterol. 2021 11 01; 116(11):2300. View in: Pubmed

    • Re: "The Intersection of Disability and Pregnancy: Risks for Maternal Morbidity and Mortality" by Signore et al. J Womens Health (Larchmt). 2021 09; 30(9):1362-1363. View in: Pubmed

    • Professional Address during Obstetrics and Gynecology Grand Rounds Introductions: Setting the Stage, Setting the Standard. J Surg Educ. 2021 Nov-Dec; 78(6):1930-1937. View in: Pubmed

    • The Matilda Effect: Underrecognition of Women in Hematology and Oncology Awards. Oncologist. 2021 09; 26(9):779-786. View in: Pubmed

    • Evidence to Date: Evaluating Pembrolizumab in the Treatment of Extensive-Stage Small-Cell Lung Cancer. Clin Pract. 2021 Jul 06; 11(3):441-454. View in: Pubmed

    • Work Patterns of Women Physicians During Vacation: A Cross-Sectional Study. J Womens Health (Larchmt). 2022 04; 31(4):573-579. View in: Pubmed

    • Sociodemographic disparities in the management of advanced lung cancer: a narrative review. J Thorac Dis. 2021 Jun; 13(6):3772-3800. View in: Pubmed

    • COVID-19 and Global Oncology: A Year in Review. JCO Glob Oncol. 2021 05; 7:797-801. View in: Pubmed

    • It Can Wait. Oncologist. 2021 05; 26(5):439-440. View in: Pubmed

    • #LatinasInMedicine: Using the Hashtag to Build Community in Medicine. J Grad Med Educ. 2021 Jun; 13(3):332-334. View in: Pubmed

    • Care without a compass: Including patients with cancer in COVID-19 studies. Cancer Cell. 2021 07 12; 39(7):895-896. View in: Pubmed

    • Videoconferencing Etiquette: Promoting Gender Equity During Virtual Meetings. J Womens Health (Larchmt). 2021 04; 30(4):460-465. View in: Pubmed

    • Evaluating Bias in Speaker Introductions at the American Society for Radiation Oncology Annual Meeting. Int J Radiat Oncol Biol Phys. 2021 06 01; 110(2):303-311. View in: Pubmed

    • Evaluating Speaker Introductions at the American Society for Radiation Oncology Annual Meeting. Int J Radiat Oncol Biol Phys. 2020 12 01; 108(5):1400-1401. View in: Pubmed

    • Lung-cancer researchers and clinicians must pay more attention to women. Nature. 2020 11; 587(7834):S13. View in: Pubmed

    • Assessing vitamin D and mammographic breast density in Alaskan women. Clin Pract. 2020 Oct 15; 10(4):1253. View in: Pubmed

    • The HOLA COVID-19 Study: An International Effort to Determine How COVID-19 Has Impacted Oncology Practices in Latin America. Cancer Cell. 2020 11 09; 38(5):605-608. View in: Pubmed

    • Oncology training in Latin America: are we ready for 2040? Lancet Oncol. 2020 10; 21(10):1267-1268. View in: Pubmed

    • The Dragon. Oncologist. 2020 10; 25(10):903-904. View in: Pubmed

    • Leveraging Social Media for Cardio-Oncology. Curr Treat Options Oncol. 2020 08 13; 21(10):83. View in: Pubmed

    • Unconscious Bias in Speaker Introductions at a Surgical Oncology Meeting: Hierarchy Reigns Over Gender. Ann Surg Oncol. 2020 Oct; 27(10):3754-3761. View in: Pubmed

    • Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination. Pancreatology. 2020 Sep; 20(6):1115-1122. View in: Pubmed

    • Cancer Care for All? Tales of Caring for Undocumented Patients with Cancer. Oncologist. 2020 07; 25(7):552-554. View in: Pubmed

    • Pulmonary Complications Secondary to Immune Checkpoint Inhibitors. Int J Chronic Dis. 2020; 2020:4928648. View in: Pubmed

    • Osimertinib-Induced Cardiomyopathy. JACC Case Rep. 2020 Apr; 2(4):641-645. View in: Pubmed

    • Gender differences in publication rates in oncology: Looking at the past, present, and future. Cancer. 2020 06 15; 126(12):2759-2761. View in: Pubmed

    • It Is Time to Talk About Fertility and Immunotherapy. Oncologist. 2020 04; 25(4):277-278. View in: Pubmed

    • Reply to On the proportion of male breast cancer among all breast cancers. Cancer. 2020 01 01; 126(9):2034-2035. View in: Pubmed

    • Evaluating Unconscious Bias: Speaker Introductions at an International Oncology Conference. J Clin Oncol. 2019 12 20; 37(36):3538-3545. View in: Pubmed

    • Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century. Cancer. 2020 01 01; 126(1):26-36. View in: Pubmed

    • Primary neuroendocrine carcinoma of the brain. BMJ Case Rep. 2019 Sep 18; 12(9). View in: Pubmed

    • Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2020 05; 21(3):e115-e129. View in: Pubmed

    • Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment. Mayo Clin Proc. 2019 08; 94(8):1623-1640. View in: Pubmed

    • Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis. JAMA Oncol. 2019 Jul 01; 5(7):1008-1019. View in: Pubmed

    • Establishing a Mutually Respectful Environment in the Workplace: A Toolbox for Performance Excellence. Am Soc Clin Oncol Educ Book. 2019 Jan; 39:e219-e226. View in: Pubmed

    • The State of Cancer Care in Venezuela. J Glob Oncol. 2019 05; 5:JGO1900031. View in: Pubmed

    • Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal? Oncologist. 2019 11; 24(11):e1148-e1155. View in: Pubmed

    • Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials. Oncologist. 2019 01; 24(1):96-102. View in: Pubmed

    • Pompe Disease Could Mimic Exam Findings of Amyloidosis: Two Rare Diagnoses Bona Fide. Case Rep Hematol. 2018; 2018:9615834. View in: Pubmed

    • Commentary: Race and Ethnicity in Biomedical Research - Classifications, Challenges, and Future Directions. Ethn Dis. 2018; 28(4):561-564. View in: Pubmed

    • Hemolytic Uremic Syndrome Associated With Escherichia coli O157 Infection in an Allogenic Stem Cell Transplant Recipient. Mayo Clin Proc Innov Qual Outcomes. 2018 Dec; 2(4):387-391. View in: Pubmed

    • Narjust Duma on How Gender Affects the Tolerability of Immunotherapy. Oncology (Williston Park). 2018 07 15; 32(7):332-3. View in: Pubmed

    • Where Do We Stand on the Integration of PARP Inhibitors for the Treatment of Breast Cancer? Curr Oncol Rep. 2018 06 08; 20(8):63. View in: Pubmed

    • Exclusion of Male Patients in Breast Cancer Clinical Trials. JNCI Cancer Spectr. 2018 Apr; 2(2):pky018. View in: Pubmed

    • Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors. J Natl Compr Canc Netw. 2018 05; 16(5):526-534. View in: Pubmed

    • Representation of Minorities and Elderly Patients in Multiple Myeloma Clinical Trials. Oncologist. 2018 09; 23(9):1076-1078. View in: Pubmed

    • Preventing Today's Survivors of Breast Cancer From Becoming Tomorrow's Cardiac Patients. J Oncol Pract. 2018 04; 14(4):213-214. View in: Pubmed

    • Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years. J Oncol Pract. 2018 01; 14(1):e1-e10. View in: Pubmed

    • Immune-Mediated Autonomic Neuropathies following Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia. Case Rep Hematol. 2017; 2017:6803804. View in: Pubmed

    • Gastric adenocarcinoma: clinicopathologic differences among Hispanics and non-Hispanic whites. A single Institution's experience over 14 years. Ann Gastroenterol. 2016 Jul-Sep; 29(3):325-31. View in: Pubmed

    • Safety and tolerability of pomalidomide-based regimens (pomalidomide-carfilzomib-dexamethasone with or without cyclophosphamide) in relapsed/refractory multiple myeloma and severe renal dysfunction: a case series. Hematol Oncol. 2017 Jun; 35(2):246-251. View in: Pubmed

    • Enlarging Pancreatic Schwannoma: A Case Report and Review of the Literature. Clin Pract. 2015 Nov 05; 5(4):793. View in: Pubmed

    • Bronchial-oesophageal fistula: a rare initial presentation of squamous cell carcinoma of the lung. BMJ Case Rep. 2015 Jun 10; 2015. View in: Pubmed

    • Prevalence, detection and treatment of anxiety, depression, and delirium in the adult critical care unit. Psychosomatics. 2001 Sep-Oct; 42(5):391-6. View in: Pubmed


    Location Avtar

    Dana-Farber Cancer Institute - Chestnut Hill

    300 Boylston Street Newton, MA 02459
    Get Directions

    Dana-Farber Cancer Institute - Chestnut Hill

    Location Avtar

    Dana-Farber Cancer Institute - Chestnut Hill

    300 Boylston Street Newton, MA 02459
    Get Direction
    42.3192, -71.1798

    Ratings and Comments

    Narjust Florez, MD

    About Our Ratings

    Physician Star Rating Comment Block